Skip to main content
. 2021 Dec 20;22(24):13650. doi: 10.3390/ijms222413650

Table 1.

Characteristics of circulating biomarkers and tumor biopsy.

Circulating Biomarkers
and Liquid Biopsy
Tumor Biopsy
Material derived from cancer detectable in bloodstream, urine, or peritoneal fluid Material obtained from a sampling of tissue lesion
Non-invasive procedure High invasive procedure
Real-time follow up Impracticable for real-time follow up
Quick and easily repeatable procedure for obtaining the samples Difficult to repeat and depend on the correctness of the procedure
No surgical complication or pain Risk of surgical complication and pain
Lack of well-defined practice rules and standardizing protocols Clinically validated and standard for histologic diagnosis
Less cost (with some exceptions) High cost
Assessment of tumor heterogeneity in different phases of the disease Failure to reflect tumor heterogeneity
Low concentrations and easily degradable material Higher concentration and fixed material
Less specificity Higher specificity
Specialized laboratory Histology laboratory